Literature DB >> 11559756

Incomplete RNA polymerase II phosphorylation in Xenopus laevis early embryos.

B Palancade1, S Bellier, G Almouzni, O Bensaude.   

Abstract

Phosphorylation of RNA polymerase II largest subunit on its C-terminal domain (CTD) heptapeptide repeats has been shown to play a key role in the regulation of mRNA synthesis and processing. In many higher metazoans, early embryos do not synthesise mRNAs during the first cell cycles following fertilisation. Transcription resumes and becomes an absolute requirement for development after several cell cycles characteristic of each species. Therefore, CTD phosphorylation has been investigated during early development of the African clawed-frog Xenopus laevis. Fertilisation is shown to trigger an abrupt dephosphorylation of the CTD. Phosphorylation of the CTD resumes concurrently with the mid-blastula transition (MBT). Both are advanced with polyspermy and increased temperatures; they do not occur when replication is impaired with aphidicolin. In Xenopus laevis somatic cells, a set of monoclonal antibodies defined distinct phosphoepitopes on the CTD. Two of them were absent before the MBT indicating that the CTD lacks the phosphorylation at the serine-2 position of the heptapeptide. The possible contribution of RNA polymerase II phosphorylation to the developmental-regulation of maternal mRNA processing in embryos is discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11559756     DOI: 10.1242/jcs.114.13.2483

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  16 in total

1.  Repression of zygotic gene expression in the Xenopus germline.

Authors:  Thiagarajan Venkatarama; Fangfang Lai; Xueting Luo; Yi Zhou; Karen Newman; Mary Lou King
Journal:  Development       Date:  2010-02       Impact factor: 6.868

2.  Smicl is required for phosphorylation of RNA polymerase II and affects 3'-end processing of RNA at the midblastula transition in Xenopus.

Authors:  Clara Collart; Joana M Ramis; Thomas A Down; James C Smith
Journal:  Development       Date:  2009-10       Impact factor: 6.868

Review 3.  The epigenome in early vertebrate development.

Authors:  Ozren Bogdanović; Simon J van Heeringen; Gert Jan C Veenstra
Journal:  Genesis       Date:  2011-12-27       Impact factor: 2.487

Review 4.  Specifying and protecting germ cell fate.

Authors:  Susan Strome; Dustin Updike
Journal:  Nat Rev Mol Cell Biol       Date:  2015-07       Impact factor: 94.444

5.  Transcription-independent RNA polymerase II dephosphorylation by the FCP1 carboxy-terminal domain phosphatase in Xenopus laevis early embryos.

Authors:  B Palancade; M F Dubois; M E Dahmus; O Bensaude
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

6.  An essential role for the RNA-binding protein Smaug during the Drosophila maternal-to-zygotic transition.

Authors:  Beatrice Benoit; Chun Hua He; Fan Zhang; Sarah M Votruba; Wael Tadros; J Timothy Westwood; Craig A Smibert; Howard D Lipshitz; William E Theurkauf
Journal:  Development       Date:  2009-03       Impact factor: 6.868

7.  Herpes simplex virus type 1 infection leads to loss of serine-2 phosphorylation on the carboxyl-terminal domain of RNA polymerase II.

Authors:  Kathryn A Fraser; Stephen A Rice
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

8.  TAF10 (TAF(II)30) is necessary for TFIID stability and early embryogenesis in mice.

Authors:  William S Mohan; Elisabeth Scheer; Olivia Wendling; Daniel Metzger; Làszlò Tora
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

9.  CDK-9/cyclin T (P-TEFb) is required in two postinitiation pathways for transcription in the C. elegans embryo.

Authors:  Eun Yong Shim; Amy K Walker; Yang Shi; T Keith Blackwell
Journal:  Genes Dev       Date:  2002-08-15       Impact factor: 11.361

10.  Temporal ChIP-on-Chip of RNA-Polymerase-II to detect novel gene activation events during photoreceptor maturation.

Authors:  Padmaja Tummala; Raghuveer S Mali; Eduardo Guzman; Xiao Zhang; Kenneth P Mitton
Journal:  Mol Vis       Date:  2010-02-17       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.